Genpharmasec Limited (BOM:531592)
India · Delayed Price · Currency is INR 1.040
0.00 (0.00%)
At close: Jul 31, 2026
Genpharmasec Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 576 | 432 | 1,009 | 1,235 | 861 | 1,523 | |
Market Cap Growth | -45.23% | -57.18% | -18.31% | 43.41% | -43.45% | -31.34% |
Enterprise Value | 818 | 491 | 1,021 | 1,221 | 805 | 1,447 |
Last Close Price | 1.04 | 0.78 | 1.89 | 2.23 | 1.87 | 3.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 39.76 | 26.94 | 81.93 | - | 76.55 | - |
PS Ratio | 0.41 | 0.31 | 2.99 | 4.06 | 3.38 | 5.57 |
PB Ratio | 0.88 | 0.66 | 1.55 | 1.91 | 5.62 | 9.91 |
P/TBV Ratio | 1.20 | 0.90 | 1.55 | 1.92 | 5.62 | 9.91 |
P/OCF Ratio | - | - | 33.78 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.58 | 0.35 | 3.03 | 4.01 | 3.15 | 5.30 |
EV/EBITDA Ratio | 66.96 | 40.15 | - | 5926.15 | 300.20 | - |
EV/EBIT Ratio | - | - | - | 31302.23 | 324.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.53 | 0.53 | 0.08 | 0.06 | 0.20 | - |
Debt / EBITDA Ratio | 28.59 | 28.59 | 82.19 | 84.54 | 11.50 | - |
Net Debt / Equity Ratio | 0.38 | 0.38 | -0.01 | -0.28 | -0.04 | -0.39 |
Net Debt / EBITDA Ratio | 20.35 | 20.35 | 2.34 | -868.31 | -2.14 | 11.40 |
Net Debt / FCF Ratio | -1.38 | -1.38 | 0.35 | 6.04 | 0.19 | 2.45 |
Asset Turnover | 1.28 | 1.28 | 0.45 | 0.67 | 1.23 | 1.11 |
Inventory Turnover | 12.18 | 12.18 | 3.99 | 2.93 | 2.75 | 4.22 |
Quick Ratio | 0.84 | 0.84 | 2.02 | 11.58 | 4.54 | 2.02 |
Current Ratio | 1.71 | 1.71 | 2.78 | 15.16 | 9.17 | 3.43 |
Return on Equity (ROE) | 0.86% | 0.86% | 1.90% | -0.42% | 7.33% | -1.16% |
Return on Assets (ROA) | -0.54% | -0.54% | -0.62% | 0.01% | 0.75% | -1.35% |
Return on Invested Capital (ROIC) | -0.67% | -0.70% | -0.88% | -0.01% | 2.05% | -6.79% |
Return on Capital Employed (ROCE) | -1.00% | -1.00% | -1.10% | 0.00% | 1.40% | -3.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.78% | 3.71% | 1.22% | -0.14% | 1.31% | -0.14% |
FCF Yield | -31.38% | -41.84% | -2.70% | -2.40% | -3.57% | -1.59% |
Buyback Yield / Dilution | -10.69% | -10.69% | -80.25% | -10.96% | - | -2.06% |